We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights NVIDIA, The Coca-Cola,Thermo Fisher Scientific, Salesforce, and SAP
Read MoreHide Full Article
For Immediate Release
Chicago, IL – April 08, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include NVIDIA Corp. (NVDA - Free Report) , The Coca-Cola Company (KO - Free Report) ,Thermo Fisher Scientific Inc. (TMO - Free Report) , Salesforce, Inc. (CRM - Free Report) and SAP SE (SAP - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for NVIDIA, Coca-Cola and Thermo Fisher
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp., The Coca-Cola Company, and Thermo Fisher Scientific Inc.. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of NVIDIA have outperformed the Zacks Semiconductor - General industry over the past year (+70.6% vs. +19.4%). The Zacks analyst believes that the company is benefiting from the coronavirus-induced work and learn-from-home wave. It is also benefiting from strong growth in GeForce desktop and notebook Graphic Processing Units, which is boosting gaming revenues.
Moreover, a surge in Hyperscale demand remains a tailwind for the company's Data Center business. Expansion of NVIDIA GeForce NOW is expected to drive the user base. Further, solid uptake of artificial intelligence-based smart cockpit infotainment solutions is a boon.
Additionally, collaboration with Mercedes-Benz is expected to further strengthen NVIDIA's presence in the autonomous vehicles and other automotive electronics space. However, management expects COVID-19 pandemic to negatively impact near-term revenues. Moreover, the U.S.-China trade war remains a key concern.
Shares of Coca-Cola have outperformed the Zacks Beverages - Soft drinks industry over the past year (+22.4% vs. +15.5%). The company has outpaced the industry in a year on a robust surprise trend, which continued in fourth-quarter 2021. Its top and the bottom line surpassed estimates for the fourth straight quarter.
The Zacks analyst believes that the company is benefited from the strategic transformation and ongoing recovery around the world. Revenues gained from the investments and ongoing recovery in markets, where the pandemic-led disruptions are subsiding. Strength across the majority of the markets, investments in the marketplace, recovery in certain markets as well as the cycling of last year's pandemic-led impacts aided volumes.
The company provided an upbeat 2022 view. It is poised to gain from innovations and accelerating digital investments. However, pressures from higher supply chain costs, including transportation and input costs remain. Higher marketing spending is also concerning.
Shares of Thermo Fisher have outperformed the Zacks Medical - Instruments industry over the past year (+24.9% vs. +0.4%). The company delivered 8% organic growth in the base business, which is ahead of streets expectations. It witnessed robust year-over-year revenue growth across the Analytical Instruments and the Laboratory Products and Biopharma Services segments.
The Zacks analyst believes that the company's strategic acquisitions of PPD, Inc. and PeproTech raise investors' confidence. Thermo Fisher's accelerated investments to expand bioproduction capacity also buoy optimism. The upbeat guidance for 2022 is indicative that this growth momentum will continue.
However, the year-over-year decline in fourth-quarter earnings raises apprehension. The decline in revenues in the other two segments is also disappointing. Contraction of both margins does not bode well either.
Other noteworthy reports we are featuring today include Salesforce, Inc. and SAP SE.
Why Haven't You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights NVIDIA, The Coca-Cola,Thermo Fisher Scientific, Salesforce, and SAP
For Immediate Release
Chicago, IL – April 08, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include NVIDIA Corp. (NVDA - Free Report) , The Coca-Cola Company (KO - Free Report) ,Thermo Fisher Scientific Inc. (TMO - Free Report) , Salesforce, Inc. (CRM - Free Report) and SAP SE (SAP - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for NVIDIA, Coca-Cola and Thermo Fisher
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp., The Coca-Cola Company, and Thermo Fisher Scientific Inc.. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of NVIDIA have outperformed the Zacks Semiconductor - General industry over the past year (+70.6% vs. +19.4%). The Zacks analyst believes that the company is benefiting from the coronavirus-induced work and learn-from-home wave. It is also benefiting from strong growth in GeForce desktop and notebook Graphic Processing Units, which is boosting gaming revenues.
Moreover, a surge in Hyperscale demand remains a tailwind for the company's Data Center business. Expansion of NVIDIA GeForce NOW is expected to drive the user base. Further, solid uptake of artificial intelligence-based smart cockpit infotainment solutions is a boon.
Additionally, collaboration with Mercedes-Benz is expected to further strengthen NVIDIA's presence in the autonomous vehicles and other automotive electronics space. However, management expects COVID-19 pandemic to negatively impact near-term revenues. Moreover, the U.S.-China trade war remains a key concern.
(You can read the full research report on NVIDIA here >>>)
Shares of Coca-Cola have outperformed the Zacks Beverages - Soft drinks industry over the past year (+22.4% vs. +15.5%). The company has outpaced the industry in a year on a robust surprise trend, which continued in fourth-quarter 2021. Its top and the bottom line surpassed estimates for the fourth straight quarter.
The Zacks analyst believes that the company is benefited from the strategic transformation and ongoing recovery around the world. Revenues gained from the investments and ongoing recovery in markets, where the pandemic-led disruptions are subsiding. Strength across the majority of the markets, investments in the marketplace, recovery in certain markets as well as the cycling of last year's pandemic-led impacts aided volumes.
The company provided an upbeat 2022 view. It is poised to gain from innovations and accelerating digital investments. However, pressures from higher supply chain costs, including transportation and input costs remain. Higher marketing spending is also concerning.
(You can read the full research report on Coca-Cola here >>>)
Shares of Thermo Fisher have outperformed the Zacks Medical - Instruments industry over the past year (+24.9% vs. +0.4%). The company delivered 8% organic growth in the base business, which is ahead of streets expectations. It witnessed robust year-over-year revenue growth across the Analytical Instruments and the Laboratory Products and Biopharma Services segments.
The Zacks analyst believes that the company's strategic acquisitions of PPD, Inc. and PeproTech raise investors' confidence. Thermo Fisher's accelerated investments to expand bioproduction capacity also buoy optimism. The upbeat guidance for 2022 is indicative that this growth momentum will continue.
However, the year-over-year decline in fourth-quarter earnings raises apprehension. The decline in revenues in the other two segments is also disappointing. Contraction of both margins does not bode well either.
(You can read the full research report on Thermo Fisher here >>>)
Other noteworthy reports we are featuring today include Salesforce, Inc. and SAP SE.
Why Haven't You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.